These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8864370

  • 1. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.
    Zachariae H, Søgaard H, Heickendorff L.
    Dermatology; 1996; 192(4):343-6. PubMed ID: 8864370
    [Abstract] [Full Text] [Related]

  • 2. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
    Zachariae H, Heickendorff L, Søgaard H.
    Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
    [Abstract] [Full Text] [Related]

  • 3. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
    Zachariae H, Søgaard H, Heickendorff L.
    Acta Derm Venereol; 1989 Jan; 69(3):241-4. PubMed ID: 2566230
    [Abstract] [Full Text] [Related]

  • 4. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
    Boffa MJ, Smith A, Chalmers RJ, Mitchell DM, Rowan B, Warnes TW, Shomaf M, Haboubi NY.
    Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
    [Abstract] [Full Text] [Related]

  • 5. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD, Maddox AJ, Green CA, Tatnall F, Schofield JK, Stott DJ.
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [Abstract] [Full Text] [Related]

  • 6. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [Abstract] [Full Text] [Related]

  • 7. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
    Oogarah PK, Rowland PL, Mitchell DM, Smith A, Chalmers RJ, Rowan B, Haboubi NY.
    Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
    [Abstract] [Full Text] [Related]

  • 8. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
    Risteli J, Søgaard H, Oikarinen A, Risteli L, Karvonen J, Zachariae H.
    Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
    [Abstract] [Full Text] [Related]

  • 9. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
    Zachariae H, Aslam HM, Bjerring P, Søgaard H, Zachariae E, Heickendorff L.
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
    [Abstract] [Full Text] [Related]

  • 10. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.
    Nyfors A.
    Acta Pathol Microbiol Scand A; 1977 Jul; 85(4):511-8. PubMed ID: 899789
    [Abstract] [Full Text] [Related]

  • 11. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
    Martyn-Simmons CL, Rosenberg WM, Cross R, Wong T, Smith CH, Barker JN.
    Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
    [Abstract] [Full Text] [Related]

  • 12. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ, Kirby B, Smith A, Burrows P, Little R, Horan M, Hextall JM, Smith CH, Klaber M, Rogers S.
    Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
    [Abstract] [Full Text] [Related]

  • 13. Liver biopsies and methotrexate: a time for reconsideration?
    Zachariae H.
    J Am Acad Dermatol; 2000 Mar; 42(3):531-4. PubMed ID: 10688735
    [No Abstract] [Full Text] [Related]

  • 14. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K, Fraser AD, Layton A, Goodfield M, Gruss H, Gough A.
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC, Cássia FF, Lamy F, Chagas VL, Ramos-e-Silva M.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [Abstract] [Full Text] [Related]

  • 16. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H, Grunnet E, Sogaard H.
    Acta Derm Venereol; 1975 Jan; 55(4):291-6. PubMed ID: 52258
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
    Malatjalian DA, Ross JB, Williams CN, Colwell SJ, Eastwood BJ.
    Can J Gastroenterol; 1996 Oct; 10(6):369-75. PubMed ID: 9193771
    [Abstract] [Full Text] [Related]

  • 18. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
    Langman G, Hall PM, Todd G.
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
    [Abstract] [Full Text] [Related]

  • 19. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis.
    Kanzler MH, Gorsulowsky D.
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):509. PubMed ID: 1564165
    [No Abstract] [Full Text] [Related]

  • 20. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
    van Swelm RP, Laarakkers CM, Kooijmans-Otero M, de Jong EM, Masereeuw R, Russel FG.
    Toxicol Lett; 2013 Aug 29; 221(3):219-24. PubMed ID: 23830989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.